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Materials and Methods 
 
Unless stated otherwise, reactions were performed in flame-dried or oven-dried glassware under an ar-
gon or nitrogen atmosphere using dry, deoxygenated solvents (distilled or passed over a column of acti-
vated alumina).1  Commercially obtained reagents were used as received with the exception of dipalladi-
um tris(dibenzylideneacetone) (Pd2(dba)3), tetrakis(triphenylphosphine)palladium(0), which were stored 
in a nitrogen-filled glovebox. Dipalladium tris(para-methoxydibenzylideneacetone) (Pd2(pmdba)3),2 (S)-
t-BuPHOX,3 (S)-(CF3)3-tBuPHOX,4 were prepared by known methods. Reactions requiring external heat 
were modulated to the specified temperatures using an IKAmag temperature controller. Reaction pro-
gress was monitored by thin-layer chromatography (TLC), which was performed using E. Merck silica 
gel 60 F254 precoated glass plates (0.25 mm) and visualized by UV fluorescence quenching, potassium 
permanganate, or p-anisaldehyde staining. Silicycle SiliaFlash® P60 Academic Silica gel (particle size 
40-63 nm) was used for column chromatography. 1H and 13C NMR spectra were recorded on a Varian 
Inova 500 (500 MHz and 126 MHz, respectively), and a Bruker AV III HD spectrometer equipped with 
a Prodigy liquid nitrogen temperature cryoprobe (400 MHz and 101 MHz, respectively) and are report-
ed in terms of chemical shift relative to CHCl3 (δ 7.26 and δ 77.16, respectively). 19F NMR spectra were 
recorded on a Varian Inova 300 spectrometer (282 MHz) and are reported in terms of absolute chemical 
shift according to IUPAC standard recommendations from CFCl3. Data for 1H NMR are reported as fol-
lows: chemical shift (δ ppm) (multiplicity, coupling constant (Hz), integration). Multiplicities are re-
ported as follows: s = singlet, d = doublet, t = triplet, m = multiplet, br s = broad singlet, app t = appar-
ently triplet. Infrared (IR) spectra were recorded on a Perkin Elmer Paragon 1000 spectrometer using 
thin films deposited on NaCl plates and are reported in frequency of absorption (cm–1). Optical rotations 
were measured with a Jasco P-2000 polarimeter operating on the sodium D-line (589 nm), using a 100 
mm path-length cell and are reported as: [α]DT (concentration in g/100 mL, solvent). Analytical SFC 
was performed with a Mettler SFC supercritical CO2 analytical chromatography system utilizing Chi-
ralpak (AD-H, AS-H, IC) or Chiralcel (OD-H, OJ-H) columns (4.6 mm x 25 cm) obtained from Daicel 
Chemical Industries, Ltd. High resolution mass spectra were obtained from the Caltech Mass Spectral 
Facility using a JEOL JMS-600H. High Resolution Mass Spectrometer in fast atom bombardment 
(FAB+) ionization mode or a Agilent 6200 Series TOF with an Agilent G1978A Multimode source in 
electrospray ionization (ESI+), atmospheric pressure chemical ionization (APCI+), or mixed 
(ESI/APCI) ionization mode. Julabo Presto LH45 was used to control reaction temperatures inside the 
nitrogen-filled glovebox. 
 
 
Allyl 1-oxo-2-(2,2,2-trifluoroethyl)-1,2,3,4-tetrahydronaphthalene-2-carboxylate (4a): To a solution 
of S15 (780 mg, 3.39 mmol, 1.0 equiv) in THF (10 mL) was added LiHMDS (2M solution in THF, 4.0 
mmol, 1.2 equiv) at 0 °C, the resulting solution was allowed to stir at room temperature for 15 min. 
Then the mixture was cooled again to 0 °C, followed an addition of a THF solution (7 mL) of mesit-
yl(2,2,2-trifluoroethyl)-λ3-iodanyl trifluoromethanesulfonate6 (2.1 g, 4.4 mmol, 1.3 equiv). After 2 hours 
stirring at room temperature, the mixture was quenched with aqueous solution of NH4Cl, extracted with 
Et2O, dried over Na2SO4, filtered, and concentrated in vacuo. The crude oil was purified by column 
chromatography (SiO2, 5% EtOAc in hexane) to afford ketoester 4a (570 mg, 54% yield) as a white sol-
id; Rf = 0.43 (10:1 Hexane:EtOAc); 1H NMR (500 MHz, CDCl3) δ 8.06 (dd, J = 7.9, 1.4 Hz, 1H), 7.50 
(app td, J = 7.5, 1.5 Hz, 1H), 7.33  (app t, J = 7.7 Hz, 1H), 7.24 (d, J = 7.7 Hz, 1H), 5.82 – 5.74 (m, 1H), 
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5.20 – 5.13 (m, 2H), 4.66 – 4.54 (m, 2H), 3.26 – 3.16 (m, 1H), 3.10 – 3.00 (m, 1H), 2.98 – 2.91 (m, 2H), 
2.74 (dt, J = 14.0, 4.3 Hz, 1H), 2.35 – 2.30 (m, 1H). 13C NMR (101 MHz, CDCl3) δ 192.29, 169.54, 
143.06, 134.14, 131.25, 131.05, 128.94, 128.54, 127.08, 126.02 (q, JC-F = 278.5 Hz, 1C), 118.94, 66.58, 
54.70 (q, JC-F = 1.8 Hz, 1C), 37.35 (q, JC-F = 29.3 Hz, 1C), 29.74 (q, JC-F = 1.7 Hz, 1C), 25.83. 19F NMR 
(282 MHz, CDCl3) δ -59.46 (t, J = 11.1 Hz, 3F).  IR (thin film, NaCl) 1737, 1693, 1601, 1260, 1134 cm 
-1. HRMS (APCI/ESI) m/z calc’d for C16H16F3O3 [M+H]+: 313.1046, found: 313.1044. 
 
 
Allyl 1-oxo-2-(3,3,3-trifluoropropyl)-1,2,3,4-tetrahydronaphthalene-2-carboxylate (4b): To a sus-
pension of NaH (60% in oil, 72 mg, 1.8 mmol, 1.2 equiv) in THF (2 mL) was added a THF solution of 
S1 (345 mg, 1.5 mmol, 1.0 equiv), the mixture was allowed to stir at room temperature for 15 minutes 
followed the addition of 1,1,1-trifluoro-3-iodopropane. The resulting mixture was allowed to heat at 
60 °C for 24 hours. After cooling to room temperature, quenched with aqueous solution of NH4Cl, ex-
tracted with Et2O, dried over Na2SO4, filtered, and concentrated in vacuo. The crude oil was purified by 
column chromatography (SiO2, 10% Et2O in hexane) to afford ester 4b (148 mg, 30% yield) as a color-
less oil; Rf = 0.43 (10:1 Hexane:EtOAc); 1H NMR (500 MHz, CDCl3) δ 8.05 (dd, J = 7.9, 1.4 Hz, 1H), 
7.49 (app td, J = 7.5, 1.5 Hz, 1H), 7.33 (dd, J = 7.9 Hz, 1H), 7.23 (d, J = 7.6 Hz, 1H), 5.79 (ddt, J = 17.6, 
10.1, 5.6 Hz, 1H), 5.26 – 5.09 (m, 2H), 4.70 – 4.51 (m, 2H), 3.14 – 3.05 (m, 1H), 2.96 (dt, J = 17.4, 5.0 
Hz, 1H), 2.59 (dt, J = 13.6, 4.9 Hz, 1H), 2.47 – 2.30 (m, 1H), 2.28 – 2.06 (m, 4H). 13C NMR (101 MHz, 
CDCl3) δ 194.82, 171.10, 142.74, 133.93, 131.89, 131.25, 128.89, 128.17, 127.13, 127.09 (q, JC-F = 
277.4 Hz, 1C), 118.87, 66.08, 56.26, 31.62, 29.80 (q, JC-F = 29.1 Hz, 1C), 26.67 (q, JC-F = 3.2 Hz, 1C), 
25.90. 19F NMR (282 MHz, CDCl3) δ -66.78 (t, J = 11.1 Hz, 3F).  IR (thin film, NaCl) 1735, 1670, 1602, 
1258, 1228 cm-1. HRMS (APCI/ESI) m/z calc’d for C17H18F3O3 [M+H]+: 327.1203, found: 327.1204. 
 
 
Allyl 2-fluoro-1-oxo-1,2,3,4-tetrahydronaphthalene-2-carboxylate (4c): The title compound 4c was 
synthesized according to the known method as describe. All spectroscopic data were in agreement with 
the literature.7 1H NMR (500 MHz, CDCl3) δ 8.07 (d, J = 7.9 Hz, 1H), 7.55 (app td, J = 7.5, 1.4 Hz, 1H), 
7.36 (m, 1H), 7.28 (d, J = 7.8 Hz, 1H), 5.91 – 5.82 (m, 1H), 5.30 – 5.22 (m, 2H), 4.76 – 4.68 (m, 2H), 
3.19 (dt, J = 17.2, 5.2 Hz, 1H), 3.08 (ddd, J = 17.1, 7.8, 5.0 Hz, 1H), 2.79 – 2.70 (m, 1H), 2.60 – 2.52 
(m, 1H). 13C NMR (101 MHz, CDCl3) δ 188.51 (d, JC-F = 19.0 Hz, 1C), 167.05 (d, JC-F = 25.9 Hz, 1C), 
143.17, 134.66, 130.81, 130.47, 128.84, 128.37 (d, JC-F = 0.94 Hz, 1C), 127.29, 119.12, 93.25 (d, JC-F = 
194.2 Hz, 1C), 66.56, 31.87 (d, JC-F = 22.6 Hz, 1C), 24.83 (d, JC-F = 7.24 Hz, 1C).  19F NMR (282 MHz, 
CDCl3) δ -164.16 (ddd, J = 22.8, 11.0, 1.2 Hz, 1F). 
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To the mixture of 1,1-carbonyldiimidazole (CDI) (4.86 g, 30 mmol) and THF (15 mL) was added a so-
lution of 2-chloro allyl alcohol (20 mmol) in 15 mL of CH2Cl2 at 0 °C slowly, the resulting mixture was 
allowed to stir for 3 h at the same temperature. Most solvent was removed in vacuo and the crude prod-
uct was purified by column chromatography (SiO2, 35% EtOAc in hexane) to afford 2-
chloroallyloxycarbonyl imidazole (S2) (3.2 g, 86% yield) as a white solid; Rf = 0.15 (3:1 Hex-
ane:EtOAC); 1H NMR (500 MHz, CDCl3) δ 8.18 (m, 1H), 7.46 (m, 1H), 7.10 (dd, J = 1.6, 0.8 Hz, 1H), 
5.61 (dt, J = 2.1, 1.0 Hz, 1H), 5.55 (d, J = 2.0 Hz, 1H), 4.97 (dd, J = 1.1, 0.4 Hz, 2H). 13C NMR (101 
MHz, CDCl3) δ 148.11, 137.27, 134.40, 131.05, 117.35, 117.24, 69.30. IR (thin film, NaCl) 3137, 3122, 
1755, 1650, 892, 758 cm-1. HRMS (APCI/ESI) m/z calc’d for C7H8ClN2O2 [M+H]+: 187.0269, found: 
187.0265. 
To a solution of Tetralone (585 mg, 4 mmol, 1.0 equiv) in THF (8 mL) was added LiHMDS (2M solu-
tion in THF, 4.4 mmol, 1.1 equiv) at -78 °C, the resulting solution was allowed to stir at the same tem-
perature for 15 min. Then a THF solution (7 mL) of 2-chloroallyloxycarbonyl imidazole (S2) (896 mg, 
4.8 mmol, 1.2 equiv) was added. After 2 hours stirring at room temperature, the mixture was quenched 
with aqueous solution of NH4Cl, extracted with Et2O, dried over Na2SO4, filtered, and concentrated in 
vacuo. The crude oil was purified by column chromatography (SiO2, 5% EtOAc in hexane) to afford S3 
(718 mg, 67% yield) as a light yellow oil; Rf = 0.41 (10:1 Hexane:EtOAc); Mixture of enol ketone form 
(3/2).  1H NMR (500 MHz, CDCl3): for enol form:  δ 12.22 (s, 0.6H), 7.81 (dd, J = 7.6, 1.4 Hz, 0.6H), 
7.36 – 7.25 (m, 1.2H), 7.20 – 7.18 (m, 0.6H), 5.70 – 5.37 (m, 1.2H), 4.77 – 4.72 (m, 1.2H), 2.85 (dd, J = 
8.8, 6.7 Hz, 1.2H), 2.64 (dd, J = 8.8, 6.6 Hz, 1.2H); for ketone form δ 8.05 (dd, J = 7.9, 1.4 Hz, 0.4H), 
7.51 (app td, J = 7.5, 1.5 Hz, 0.4H), 7.36 – 7.25 (m, 0.4H), 5.67 – 5.37 (m, 0.8H), 4.80 (s, 0.8H), 3.70 
(dd, J = 10.8, 4.7 Hz, 0.4H), 3.29 – 2.93 (m, 0.8H), 2.55 (dddd, J = 13.4, 10.9, 9.6, 5.0 Hz, 0.4H), 2.48 – 
2.36 (m, 0.4H). 13C NMR (101 MHz, CDCl3): for enol form: δ 169.44, 166.16, 139.61, 135.95, 130.94, 
129.81, 128.95, 127.59, 126.73, 114.82, 96.44, 65.84, 27.78, 26.47; for ketone form: 13C NMR (101 
MHz, CDCl3) δ 192.86, 171.65, 143.67, 135.29, 134.13, 131.71, 127.84, 127.07, 124.57, 115.07, 66.40, 
54.60, 27.75, 20.50. IR (thin film, NaCl) 1750, 1686, 1651, 1617, 1597, 1569, 1266, 1212, 1132, 1085 
cm-1. HRMS (APCI/ESI) m/z calc’d for C14H14ClO2 [M+H]+: 265.0626, found: 265.0627. 
Neat TiCl4 (10 μL, 0.09 mmol, 0.09 equiv) was added to a solution of S3  (265 mg, 1.0 mmol, 1.0 
equiv) in CH3CN (5 mL), resulting in an immediate color change from pale yellow to dark orange-
brown. After 5 min, Selectfluor (425 mg, 1.2 mmol, 1.2 equiv) was added in one portion. The mixture 
was stirred vigorously at room temperature for 2 h, during which time the dark orange-brown color fad-
ed to yellow. The reaction was quenched by addition of H2O, extracted with Et2O, dried over Na2SO4, 
filtered, and concentrated in vacuo. The crude oil was purified by column chromatography (SiO2, 10% 
EtOAc in hexane) to afford ester 4d (217 mg, 77% yield) as a colorless oil;7 Rf = 0.12 (10:1 Hex-
ane:EtOAc); 1H NMR (500 MHz, CDCl3) δ 8.08 (dd, J = 7.9, 1.4 Hz, 1H), 7.56 (app td, J = 7.5, 1.4 Hz, 
1H), 7.38 (app t, J = 7.8 Hz, 1H), 7.29 (d, J = 7.7 Hz, 1H), 5.49 – 5.34 (m, 2H), 4.79 (dd, J = 13.7, 
41.56 Hz, 2H), 3.22 (ddd, J = 17.2, 7.7, 5.7 Hz, 1H), 3.11 (ddd, J = 17.2, 7.4, 5.0 Hz, 1H), 2.86 – 2.69 
(m, 1H), 2.67 – 2.53 (m, 1H). 13C NMR (101 MHz, CDCl3) δ 188.16 (d, JC-F = 18.5 Hz), 166.56 (d, JC-F 
= 26.8 Hz, 1C), 143.18, 134.78, 134.35, 130.30, 128.88, 128.37 (d, JC-F = 1.2 Hz, 1C), 127.32, 115.82, 
93.22 (d, JC-F = 194.0 Hz, 1C), 66.96, 31.79 (d, JC-F = 22.2 Hz, 1C), 24.67 (d, JC-F = 7.1 Hz, 1C). 19F 
NMR (282 MHz, CDCl3) δ -164.46 (dd, J = 23.7, 11.3 Hz, 1F). IR (thin film, NaCl) 1764, 1701, 
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1600,1272, 1184, 1084 cm-1. HRMS (APCI/ESI) m/z calc’d for C14H13ClFO3 [M+H]+: 283.0532, found: 
283.0530. 
 
 
The procedure for preparation of 2-fluoroprop-2-en-1-ol was adapted from the work of Herzon and 
coworkers.8 
Solid aluminum chloride (1.0 g, 8.78 mmol, 1.0 equiv) was added portion-wise over 10 min to a solu-
tion of lithium aluminum hydride (1.17 g, 26.3 mmol, 3.0 equiv) in Et2O (20 mL) at 0 °C. The resulting 
mixture was stirred for 30 min at 0 °C. Methyl 2-fluoroacrylate (820 μL, 8.78 mmol, 1.0 equiv) was 
then added dropwise via syringe to the mixture. The reaction mixture was stirred for 1 h at 0 °C at at-
mosphere of nitrogen. Distilled water (1.0 mL) and 15% aqueous sodium hydroxide solution (1.0 mL) 
were then added in sequence dropwise via syringe over 20 min (10 min addition of each reagent). A se-
cond portion of distilled water (3.0 mL) was then added dropwise via syringe over 5 min. The resulting 
mixture was stirred for 10 min at 0 °C. The heterogeneous mixture was filtered through a Buchner fun-
nel, and the filter cake was rinsed with Et2O (100 mL). The filtrates were combined and and dried over 
anhydrous MgSO4. The dried solution was filtered and the filtrate was concentrated (150 torr, 0 °C).  
The product is very volatile, therefore Et2O was not completely removed. The solution of 2- fluoroallyl 
alcohol in Et2O was used directly and immediately in the following step. 
To the mixture of 1,1-carbonyldiimidazole (CDI)(1.3 g, 8 mmol) and CH2Cl2 (5 mL) was added a solu-
tion of 2- fluoroallyl alcohol from last step in Et2O at 0 °C slowly, the resulting mixture was allowed to 
stir for 3 h at the same temperature. Most solvent was removed in vacuo and the crude product was puri-
fied by column chromatography (SiO2, 50% EtOAc in hexane) to afford 2-flouroallyloxycarbonyl im-
idazole (S4) (1.3 g, 86% yield over two steps) as a white solid; Rf = 0.43 (1:1 Hexane:EtOAC); 1H 
NMR (500 MHz, CDCl3) δ 8.16 (m, 1H), 7.44 (dd, J = 2.8, 1.4 Hz, 1H), 7.09 (m, 1H), 4.96 (ddd, J = 
15.1, 3.5, 1.2 Hz, 1H), 4.92 (d, J = 15.5 Hz, 2H), 4.79 (dd, J = 46.2, 3.5 Hz, 1H). 13C NMR (101 MHz, 
CDCl3) δ 158.55 (d, JC-F = 258.7 Hz, 1C), 148.26, 137.29, 131.05, 117.26, 96.83 (d, JC-F = 16.9 Hz, 1C), 
64.73 (d, JC-F = 32.7 Hz, 1C).  19F NMR (282 MHz, CDCl3) δ -105.69 – -106.02 (m, 1F). IR (thin film, 
NaCl) 1766, 1682, 1408, 1384, 1316, 1295, 1242, 1168, 997 cm-1. HRMS (APCI/ESI) m/z calc’d for 
C7H7FN2O2 [M+H]+: 171.0564, found: 171.0564. 
To a solution of Tetralone (585 mg, 4 mmol, 1.0 equiv) in THF (8 mL) was added LiHMDS (2M solu-
tion in THF, 4.8 mmol, 1.2 equiv) at -78 °C, the resulting solution was allowed to stir at the same tem-
perature for 15 min. Then a THF solution (7 mL) of 2-fluoroallyloxycarbonyl imidazole (S4) (817 mg, 
4.8 mmol, 1.2 equiv) was added. After 2 hours stirring at room temperature, the mixture was quenched 
with aqueous solution of NH4Cl, extracted with Et2O, dried over Na2SO4, filtered, and concentrated in 
vacuo. The crude oil was purified by column chromatography (SiO2, 10% Et2O in hexane) to afford S5 
(417 mg, 42% yield) as a light yellow oil; Rf = 0.43 (10:1 Hexane:EtOAc); Mixture of enol ketone form 
(3/2). 1H NMR (500 MHz, CDCl3): for enol form: δ 12.22 (s, 0.6H), 7.86 – 7.76 (m, 0.6H), 7.42 – 7.27 
(m, 1.2H), 7.22 – 7.15 (m, 0.6H), 4.86 (dd, J = 16.0, 3.2 Hz, 0.6H), 4.79 – 4.69 (m, 1.8H), 2.90 – 2.78 
(m, 1.2H), 2.69 – 2.57 (m, 1.2H); for ketone form: δ 8.09 – 8.00 (m, 0.4H), 7.51 (dd, J = 7.5, 1.5 Hz, 
0.4H), 7.38 – 7.28 (m, 0.8H), 4.83 (dd, J = 16.3, 3.3 Hz, 0.4H), 4.74 – 4.64 (m, 1.2H), 3.69 (dd, J = 
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11.0, 4.7 Hz, 0.4H), 3.13 – 2.99 (m, 0.8H), 2.57 – 2.49 (m, 0.4H), 2.44 – 2.36 (m, 0.4H). 13C NMR (101 
MHz, CDCl3): for enol form δ 169.69, 166.15, 160.39 (d, JC-F = 257.9 Hz, 0.6C), 139.69, 130.97, 
129.87, 128.97, 127.63, 124.62, 96.51, 94.56 (d, JC-F = 17.1 Hz, 0.6C), 61.31 (d, JC-F = 34.4 Hz, 0.6C), 
27.84, 26.48; for ketone form: δ 192.88, 171.88, 159.94 (d, JC-F = 257.9 Hz, 0.4C), 143.70, 134.17, 
131.75, 127.93, 127.13, 126.77, 94.63 (d, JC-F = 16.8 Hz, 0.4C), 61.89 (d, J = 34.8 Hz, 0.4C), 54.66, 
27.84, 20.55. 19F NMR (282 MHz, CDCl3) δ -105.33 – -105.98 (m, 1F).  IR (thin film, NaCl) 1749, 
1686, 1651, 1617, 1598, 1569, 1263, 1210, 1198, 1132, 1085 cm-1. HRMS (APCI/ESI) m/z calc’d for 
C14H14FO3 [M+H]+: 249.0921, found: 249.0923. 
The mixture of S5 (451 mg, 1.81 mmol, 1.0 equiv), cesium carbonate (1.29 g, 3.92 mmol, 2.0 equiv) 
and MeI (244 mL, 3.92 mmol, 2.0 equiv) in CH3CN was heated at 50 °C for 12 hours. After cooling, the 
solution was filtered and concentrated in vacuo. The crude product was purified by column chromatog-
raphy (SiO2, 10% Et2O in hexane) to furnish β-ketoester 4e (370 mg, 78% yield) as a colorless oil; Rf = 
0.28 (10:1 Hexane:EtOAC); 1H NMR (500 MHz, CDCl3) δ 8.06 (dd, J = 7.8, 1.4 Hz, 1H), 7.48 (app td, 
J = 7.5, 1.5 Hz, 1H), 7.32 (app t, J = 7.8 Hz, 1H), 7.23 (d, J = 7.8 Hz, 1H), 4.72 (dd, J = 16.1, 3.3 Hz, 
1H), 4.69 – 4.54 (m, 2H), 4.48 (dd, J = 3.3, 47.7 Hz, 1H), 3.06 (ddd, J = 17.4, 9.3, 4.9 Hz, 1H), 2.97 (dt, 
J = 17.3, 5.5 Hz, 1H), 2.70 (ddd, J = 13.6, 6.2, 4.8 Hz, 1H), 2.15 (ddd, J = 13.9, 9.2, 4.9 Hz, 1H), 1.54 (s, 
3H). 13C NMR (101 MHz, CDCl3) δ 195.79, 172.35, 159.79 (d, JC-F = 258.7 Hz, 1C), 143.16, 133.76, 
131.59, 128.90, 128.22, 127.02, 94.15 (d, JC-F = 16.5 Hz, 1C), 61.72 (d, JC-F = 35.2 Hz, 1C), 54.07, 
33.81, 25.95, 20.47. 19F NMR (282 MHz, CDCl3) δ -106.01 – -106.32 (m, 1F). IR (thin film, NaCl) 
1738, 1682, 1601, 1227, 1164 cm-1. HRMS (APCI/ESI) m/z calc’d for C15H16FO3 [M+H]+: 263.1078, 
found: 263.1078. 
 
 
The procedure for preparation of 4f was adapted from the work of Shibata and coworkers.9 
To a stirred solution of methyl 1-oxo-1,2,3,4-tetrahydronaphthalene-2-carboxylate10 (224 mg, 1.1 
mmol, 1.0 equiv) in CH3CN (11 mL) was added DBU (328 mL, 2.2 mmol, 2.0 equiv) at room tempera-
ture. After stirring at room temperature for 15 min, the mixture was cooled down to 0 °C and a solution 
of the trifluoromethylating reagent (561 mg, 1.65 mmol, 1.5 equiv.) in acetonitrile (11 mL) was added 
dropwise at the same temperature. Reaction mixture was stirred 10 min, and then warmed up to room 
temperature, the solvent was evaporated, and the crude product was purified by column chromatography 
(SiO2, 10% EtOAc in pentane) to furnish α-trifluoromethyl-β-ketoester S6 (281mg, 94% yield) as a 
colorless oil; Rf = 0.18 (10:1 Hexane:EtOAc).  
To a stirred solution of S6 (281mg, 1.03 mmol, 1.0 equiv) in allyl alcohol (30.0 equiv.) was added 
Ti(OiPr)4 (2.0 equiv) at 80 °C under nitrogen atmosphere. After reaction mixture was stirred at the same 
temperature for 24 h, it was cooled down to room temperature and quenched with aqueous solution of 
NH4Cl. Aqueous layer was extracted with CH2Cl2 (20 mL x 4), and the combined organic layers was 
washed with brine, dried over Na2SO4, filtered, and concentrated in vacuo. The crude oil was purified by 
column chromatography (SiO2, 10% EtOAc in hexane) to afford 4f (242 mg, 74% yield) as a light yel-
low oil; Rf = 0.50 (5:1 Hexane:EtOAc); All spectroscopic data were in agreement with the literature.9 1H 
NMR (500 MHz, CDCl3) δ 8.12 (dd, J = 7.8, 1.4 Hz, 1H), 7.53 (app td, J = 7.5, 1.4 Hz, 1H), 7.38 –7.32 
(m, 1H), 7.24 (d, J = 7.8 Hz, 1H), 5.92 – 5.67 (m, 1H), 5.32 – 5.07 (m, 2H), 4.84 – 4.56 (m, 2H), 3.22 – 
2.97 (m, 2H), 2.85 (dt, J = 13.6, 4.2 Hz, 1H), 2.50 (ddd, J = 13.6, 10.3, 6.7 Hz, 1H). 13C NMR (101 
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MHz, CDCl3) δ 187.09, 165.11 (q, JC-F = 1.9 Hz, 1C), 142.14, 134.44, 131.62 (q, JC-F = 1.5 Hz, 1C), 
130.53, 128.82, 128.54, 127.44, 123.95 (q, JC-F = 284.0 Hz, 1C), 119.28, 67.09, 62.15 (q, JC-F = 24.1 Hz, 
1C), 27.83 (q, JC-F = 2.3 Hz, 1C), 25.19. 19F NMR (282 MHz, CDCl3) δ -68.73 (s, 3F). 
 
 
Allyl 1-oxo-2-(2,2,2-trifluoroethyl)-2,3-dihydro-1H-indene-2-carboxylate (4g) was synthesized using 
the same method with 4a from allyl 1-oxo-2,3-dihydro-1H-indene-2-carboxylate (S7)11. The crude oil 
was purified by column chromatography (SiO2, 50% CH2Cl2 in hexane) to afford 4g (110 mg, 37% 
yield) as a light yellow oil; Rf = 0.38 (1:1 Hexane:CH2Cl2); 1H NMR (500 MHz, CDCl3) δ 7.78 (dd, J = 
7.7, 0.9 Hz, 1H), 7.66 (app td, J = 7.5, 1.2 Hz, 1H), 7.53 (app dt, J = 7.7, 1.0 Hz, 1H), 7.42 (app td, J = 
7.9, 0.9 Hz, 1H), 5.81 (ddt, J = 17.2, 10.5, 5.6 Hz, 1H), 5.39 – 5.15 (m, 2H), 4.64 – 4.53 (m, 2H), 3.88 
(d, J = 17.3 Hz, 1H), 3.52 – 3.15 (m, 2H), 2.66 (dq, J = 15.5, 10.5 Hz, 1H). 13C NMR (101 MHz, 
CDCl3) δ 199.24, 168.43, 153.15, 136.10, 133.83, 131.18, 128.20, 126.50, 126.10 (q, JC-F = 277.7 Hz, 
1C), 125.32, 118.86, 66.91, 57.37 (q, JC-F = 1.9 Hz, 1C), 37.62 (q, JC-F = 29.1 Hz, 1C), 35.34 (q, JC-F = 
1.7 Hz 1C). 19F NMR (282 MHz, CDCl3) -60.61 (t, J = 10.5 Hz, 3F).  IR (thin film, NaCl) 1745, 1719, 
1608, 1257, 1169 cm-1. HRMS (APCI/ESI) m/z calc’d for C15H14F3O3 [M+H]+: 299.0890, found: 
299.0898. 
 
 
Allyl 1-oxo-2-(3,3,3-trifluoropropyl)-2,3-dihydro-1H-indene-2-carboxylate (4h): The mixture of al-
lyl 1-oxo-2,3-dihydro-1H-indene-2-carboxylate (S8) (216 mg, 1.0 mmol, 1.0 equiv), Cesium car-
bonate (652 mg, 2.0 mmol, 2.0 equiv) and 1,1,1-trifluoro-3-iodopropane (447 mL, 2.0 mmol, 2.0 equiv) 
in CH3CN (5 mL) was heated at 50 °C for 48 hours. After cooling, the solution was filtered and concen-
trated in vacuo. The crude product was purified by column chromatography (SiO2, 50% CH2Cl2 in hex-
ane) to furnish β-ketoester 4h (98 mg, 31% yield) as a colorless oil; Rf = 0.37 (1:1 Hexane:CH2Cl2); 1H 
NMR (500 MHz, CDCl3) δ 7.80 (ddd, J = 7.7, 1.3, 0.8 Hz, 1H), 7.66 (app td, J = 7.5, 1.2 Hz, 1H), 7.50 
(app dt, J = 7.7, 0.9 Hz, 1H), 7.44 (ddd, J = 7.9, 7.2, 0.9 Hz, 1H), 5.83 (ddt, J = 17.1, 10.4, 5.6 Hz, 1H), 
5.34 – 5.14 (m, 2H), 4.69 – 4.54 (m, 2H), 3.73 (d, J = 17.2 Hz, 1H), 3.06 (d, J = 17.2 Hz, 1H), 2.39 – 
2.24 (m, 2H), 2.22 – 2.06 (m, 2H). 13C NMR (101 MHz, CDCl3) δ 201.52, 170.28, 152.45, 135.93, 
134.96, 131.37, 128.34, 126.89 (q, JC-F = 275.9 Hz, 1C), 126.58, 125.20, 118.83, 66.36, 58.81, 37.62, 
29.70 (q, JC-F = 29.2 Hz, 1C), 27.16 (q, JC-F = 3.3 Hz, 1C).  19F NMR (282 MHz, CDCl3) δ -66.70 (t, J = 
10.1 Hz, 3F).  IR (thin film, NaCl) 1741, 1711, 1255, 1141 cm-1. HRMS (APCI/ESI) m/z calc’d for 
C16H16F3O3 [M+H]+: 313.1046, found: 313.1040. 
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2-Fluoroallyl 1-oxo-2,3-dihydro-1H-indene-2-carboxylate (S9) was synthesized using the same 
method with S5 from 1-Indanone and S4. The crude oil was purified by column chromatography (SiO2, 
20% Et2O in hexane) to afford S9 (515 mg, 73% yield) as a colorless oil; Rf = 0.28 (10:1 Hexane: 
EtOAc); Mixture of enol ketone form (1/4). 1H NMR (300 MHz, CDCl3): ketone form δ 7.82 – 7.74 (m, 
0.8H), 7.69 – 7.59 (m, 0.8H), 7.56 – 7.47 (m, 0.8H), 7.47 – 7.36 (m, 0.8H), 4.95 – 4.57 (m, 3.2H), 3.79 
(dd, J = 8.3, 4.2 Hz, 0.8H), 3.70 – 3.51 (m, 0.8H), 3.49 – 3.30 (m, 0.8H). 13C NMR (101 MHz, CDCl3): 
ketone form δ 199.00, 168.60, 159.81 (d, JC-F = 257.5 Hz, 0.8C), 153.54, 135.70, 135.23, 128.06, 
126.70, 124.92, 94.69 (d, JC-F = 16.6 Hz, 0.8C), 62.20 (d, JC-F = 35.1 Hz, 0.8C), 53.16, 30.38. 19F NMR 
(282 MHz, CDCl3) δ -105.40 – -105.71 (m, 0.2F), -105.72 – -106.08 (m, 0.8F).  IR (thin film, NaCl) 
1745, 1713, 1685, 1204, 1150, 761 cm-1; HRMS (APCI/ESI) m/z calc’d for C13H10FO3 [M-H]–: 
233.0619, found: 233.0618. 
2-Fluoroallyl 2-fluoro-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (4i) was synthesized using the 
same method with 4d from S9. The crude oil was purified by column chromatography (SiO2, 10% 
EtOAc in hexane) to afford 4i (176 mg, 70% yield) as a pale solid; Rf  = 0.28 (10:1 Hexane:EtOAc);  1H 
NMR (500 MHz, CDCl3) δ 7.85 (dd, J = 7.7, 0.7 Hz, 1H), 7.72 (app td, J = 7.5, 1.2 Hz, 1H), 7.55 – 7.43 
(m, 2H), 4.85 – 4.64 (m, 3H), 4.60 (dd, J = 47.0, 3.5 Hz, 1H), 3.82 (dd, J = 17.7, 11.7 Hz, 1H), 3.48 (dd, 
J = 23.3, 17.6 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 194.81 (d, J C-F = 18.2 Hz, 1C), 166.79 (d, J C-F = 
28.5 Hz, 1C), 158.91 (d, JC-F = 257.6 Hz, 1C), 150.85 (d, J C-F = 3.4 Hz, 1C), 137.02, 133.20, 128.88, 
126.76 (d, JC-F = 1.3 Hz, 1C), 125.87 (d, JC-F = 1.1 Hz, 1C), 95.41 (d, J = 16.6 Hz, 1C), 94.57 (d, JC-F = 
202.0 Hz, 1C), 62.67 (d, JC-F = 34.7 Hz, 1C), 38.33 (d, JC-F = 23.8 Hz, 1C). 19F NMR (282 MHz, CDCl3) 
δ -106.19 – -106.51 (m, 1F), -164.54 (dd, J = 23.3, 11.9 H, 1F).  IR (thin film, NaCl) 1771, 1724, 1600, 
1282, 1184, 1071 cm-1. HRMS (APCI/ESI) m/z calc’d for C13H11F2O2 [M+H]+: 253.0671, found: 
253.0672. 
 
 
2-Fluoroallyl 2-methyl-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (4j) was synthesized using the 
same method with 4e from S10. The crude oil was purified by column chromatography (SiO2, 100% 
CH2Cl2) to afford 4j (170 mg, 69% yield) as a colorless oil; Rf = 0.34 (10:1 Hexane:EtOAc); 1H NMR 
(500 MHz, CDCl3) δ 7.80 (dd, J = 7.7, 0.5 Hz, 1H), 7.64 (app td, J = 7.5, 1.2 Hz, 1H), 7.49 (app dt, J = 
7.7, 1.0 Hz, 1H), 7.45 – 7.40 (m, 1H), 4.75 (dd, J = 16.1, 3.3 Hz, 1H), 4.70 – 4.47 (m, 3H), 3.74 (dd, J = 
17.1, 0.9 Hz, 1H), 3.04 (dq, J = 17.0, 0.7 Hz, 1H), 1.55 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 203.01, 
171.38, 159.77 (d, JC-F = 257.4 Hz, 1C), 152.58, 135.62, 134.61, 128.07, 126.63, 125.18, 94.21 (d, JC-F = 
16.6 Hz, 1C), 61.90 (d, JC-F = 35.4 Hz, 1C), 56.08, 40.04, 21.13.  19F NMR (282 MHz, CDCl3) δ -106.09 
– -106.41 (m, 1F). IR (thin film, NaCl) 1748, 1712, 1606, 1280, 1156, 1091 cm-1; HRMS (APCI/ESI) 
m/z calc’d for C14H14FO3 [M+H]+: 249.0921, found: 249.0919. 
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Allyl 1-benzoyl-2-oxo-3-(3,3,3-trifluoropropyl)piperidine-3-carboxylate (4k) was synthesized using 
the same method with 4b from allyl 1-benzoyl-2-oxopiperidine-3-carboxylate (S11) 12. The crude oil 
was purified by column chromatography (SiO2, 100% CH2Cl2) to afford 4k (142 mg, 37% yield) as a 
colorless oil; Rf = 0.54 (3:1 Hexane:EtOAc); 1H NMR (500 MHz, CDCl3) δ 7.75 – 7.70 (m, 2H), 7.52 – 
7.48 (m, 1H), 7.41 – 7.38 (m, 2H), 5.99 (ddt, J = 17.2, 10.4, 6.1 Hz, 1H), 5.43 (dq, J = 17.1, 1.4 Hz, 
1H), 5.37 (dq, J = 10.4, 1.1 Hz, 1H), 4.76 (dq, J = 6.1, 1.1 Hz, 2H), 3.87 – 3.25 (m, 2H), 2.52 – 2.40 (m, 
1H), 2.42 – 2.28 (m, 1H), 2.18 – 1.99 (m, 5H), 1.87 (ddd, J = 13.7, 9.6, 5.9 Hz, 1H). 13C NMR (101 
MHz, CDCl3) δ 174.99, 171.51, 171.21, 135.65, 132.12, 131.09, 128.31 (2C), 128.22 (2C), 126.89 (q, 
JC-F = 276.4 Hz, 1C), 120.47, 67.02, 55.42, 46.71, 31.71, 29.97 (q, JC-F = 29.0 Hz), 28.41 (q, JC-F = 3.3 
Hz, 1C), 20.24. 19F NMR (282 MHz, CDCl3) δ -66.79 (t, J = 10.1 Hz, 3F). IR (thin film, NaCl) 1735, 
1685, 1451, 1393, 1276, 1256, 1147 cm-1. HRMS (APCI/ESI) m/z calc’d for C19H21F3NO4 [M+H]+: 
384.1417, found: 384.1414. 
 
 
2-Fluoroallyl 1-benzoyl-2-oxopiperidine-3-carboxylate (S12) was synthesized using the same method 
with S5 from 1-benzoylpiperidin-2-one and S4. The crude oil was purified by column chromatography 
(SiO2, 100% CH2Cl2) to afford S12 (482 mg, 53% yield) as a colorless oil; Rf = 0.37 (3:1 Hexane: 
EtOAc); 93% purity, ketone form. 1H NMR (500 MHz, CDCl3) δ 7.73 – 7.64 (m, 2H), 7.52 – 7.46 (m, 
1H), 7.42 – 7.36 (m, 2H), 4.87 (ddd, J = 15.6, 3.4, 0.6 Hz, 1H), 4.78 – 4.64 (m, 3H), 3.95 – 3.78 (m, 
2H), 3.64 (t, J = 6.6 Hz, 1H), 2.39 – 2.32 (m, 1H), 2.26 – 2.18 (m, 1H), 2.14 – 2.06 (m, 1H), 2.03 – 1.93 
(m, 1H). 13C NMR (101 MHz, CDCl3) δ 174.60, 169.34, 169.05, 159.56 (d, JC-F = 258.1 Hz, 1C), 
135.46, 132.06, 128.33 (2C), 128.29 (2C), 95.53 (d, JC-F = 16.9 Hz, 1C), 62.51 (d, JC-F = 33.1 Hz, 1C), 
51.03, 46.40, 25.59, 20.75.  19F NMR (282 MHz, CDCl3) δ -105.57 (dq, J = 46.2, 15.1 Hz, 1F). IR (thin 
film, NaCl) 1744, 1682, 1449, 1394, 1283, 1257, 1151, 1114 cm-1. HRMS (APCI/ESI) m/z calc’d for 
C16H17FNO4 [M+H]+: 306.1136, found: 306.1131. 
2-Fluoroallyl 1-benzoyl-3-methyl-2-oxopiperidine-3-carboxylate (4l) was synthesized using the same 
method with 4e from S12. The crude oil was purified by column chromatography (SiO2, 100% CH2Cl2) 
to afford 4l (186 mg, 56% yield) as light yellow oil; Rf = 0.30 (3:1 Hexane:EtOAc); 1H NMR (500 MHz, 
CDCl3) δ 7.73 – 7.66 (m, 2H), 7.52 – 7.45 (m, 1H), 7.41 – 7.35 (m, 2H), 4.90 (dd, J = 15.5, 3.4 Hz, 1H), 
4.82 – 4.63 (m, 3H), 3.89 (dt, J = 12.8, 7.1 Hz, 1H), 3.83 – 3.76 (m, 1H), 2.68 – 2.43 (m, 1H), 2.12 – 
1.96 (m, 2H), 1.91 – 1.80 (m, 1H), 1.52 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 175.06, 172.57, 172.32, 
159.58 (d, JC-F = 258.4 Hz, 1C), 135.91, 131.84, 128.22 (2C), 128.06 (2C), 95.76 (d, JC-F = 17.0 Hz, 1C), 
62.63 (d, JC-F = 32.5 Hz, 1C), 52.99, 46.91, 33.87, 22.58, 20.25. 19F NMR (282 MHz, CDCl3) δ-105.20 – 
-105.53 (m, 1F). IR (thin film, NaCl) 1718, 1684, 1458, 1390, 1276, 1189, 1127 cm-1; HRMS 
(APCI/ESI) m/z calc’d for C17H19FNO4 [M+H]+: 320.1293, found: 320.1298. 
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Allyl 1-(benzyloxy)-2,6-dioxo-3-(3,3,3-trifluoropropyl)piperidine-3-carboxylate (4m) was synthe-
sized using the same method with 4h from allyl 1-(benzyloxy)-2,6-dioxopiperidine-3-carboxylate 
(S13)13 except that the temperature was 70 °C and reaction time was 24 hours. The crude oil was puri-
fied by column chromatography (SiO2, 50% EtOAc in hexane) to afford 4m (120 mg, 30% yield) as a 
colorless oil; Rf = 0.28 (3:1 Hexane: EtOAc); (99.7% purity determined by 19F NMR). 1H NMR (500 
MHz, CDCl3) δ 7.53 – 7.49 (m, 2H), 7.40 – 7.34 (m, 3H), 5.87 (ddt, J = 16.5, 10.3, 6.0 Hz, 1H), 5.36 
(dq, J = 17.2, 1.4 Hz, 1H), 5.32 (dq, J = 10.4, 1.1 Hz, 1H), 5.02 (s, 2H), 4.69 (d, J = 6.1 Hz, 2H), 2.81 
(ddd, J = 18.1, 5.0, 3.3 Hz, 1H), 2.69 (ddd, J = 18.0, 12.6, 5.3 Hz, 1H), 2.49 – 2.30 (m, 1H), 2.29 – 1.98 
(m, 4H), 1.90 (td, J = 13.2, 5.0 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 169.37, 166.85, 166.65, 133.69, 
130.52, 130.24 (2C), 129.44, 128.60 (2C), 126.64 (q, JC-F = 276.4 Hz, 1C), 120.74, 77.98, 67.29, 54.56, 
30.21, 29.58 (q, JC-F = 29.5 Hz, 1C), 27.82 (q, J C-F = 3.3 Hz, 1C), 26.30. 19F NMR (282 MHz, CDCl3) δ 
-66.78 (t, J = 10.1 Hz, 3F). IR (thin film, NaCl) 1738, 1710, 1454, 1258, 1189, 1160, 1000, 977 cm-1. 
HRMS (APCI/ESI) m/z calc’d for C19H21F3NO5 [M+H]+: 400.1366, found: 400.1379. 
 
 
Allyl 1-benzoyl-2-oxo-3-(3,3,3-trifluoropropyl)pyrrolidine-3-carboxylate (4n) was synthesized using 
the same method with 4h from allyl 1-benzoyl-2-oxopyrrolidine-3-carboxylate (S14)12. The crude oil 
was purified by column chromatography (SiO2, 25% EtOAc in hexane) to afford 4n (170 mg, 46% 
yield) as a colorless oil; Rf = 0.50 (3:1 Hexane: EtOAc); 1H NMR (500 MHz, CDCl3) δ 7.62 – 7.59 (m, 
2H), 7.57 – 7.52 (m, 1H), 7.44 – 7.39 (m, 2H), 5.92 (ddt, J = 17.1, 10.3, 5.8 Hz, 1H), 5.37 (dq, J = 17.1, 
1.4 Hz, 1H), 5.32 (dq, J = 10.4, 1.2 Hz, 1H), 4.71 (dt, J = 5.8, 1.3 Hz, 2H), 4.08 (ddd, J = 11.4, 8.7, 3.6 
Hz, 1H), 3.96 (ddd, J = 11.4, 8.2, 7.7 Hz, 1H), 2.63 (ddd, J = 13.3, 7.7, 3.7 Hz, 1H), 2.54 – 2.36 (m, 
1H), 2.28 – 1.97 (m, 3H). 13C NMR (101 MHz, CDCl3) δ 171.49, 170.34, 169.63, 133.73, 132.44, 
130.95, 128.94 (2C), 128.05 (2C), 126.74 (q, JC-F = 276.0 Hz, 1C), 119.86, 66.89, 56.37, 43.49, 29.41 
(q, JC-F = 29.4 Hz, 1C), 28.62, 26.64 (q, JC-F = 3.4 Hz, 1C).  19F NMR (282 MHz, CDCl3) δ -66.79 (t, J = 
9.9 Hz, 3F). IR (thin film, NaCl) 1748, 1731, 1682, 1449, 1293, 1253, 1218, 1131 cm-1. HRMS 
(APCI/ESI) m/z calc’d for C18H19F3NO4 [M+H]+: 370.1261, found: 370.1254. 
 
Representative Procedure 1: Enantioselective Allylic Alkylation. 
Oven-dried half-dram vials were charged with the palladium source (Pd2dba3 or Pd2pmdba3, 0.005 
mmol, 0.05 equiv) and  (S)-(CF3)3-tBu-PHOX (7.4 mg, 0.0125 mmol, 0.125 equiv) and toluene (2 mL) 
in a nitrogen-filled glovebox. After stirring at ambient glovebox temperature (~28 °C) for 30 min, solu-
tions of the substrates (0.1 mmol, 1.0 equiv) in 1 mL of toluene were added. The reaction vials were 
tightly capped and removed from the glovebox. After 24 hours at ambient temperature or heating at the 
desired temperatures, the solvent was removed by vacuo. The crude mixture were separated on the pre-
parative thin layer plate, filtered, washed with Et2O, removed solvent and analyzed for enantiomeric ex-
cess and optical rotations (see Methods for the Determination of Enantiomeric Excess).  
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Representative Procedure 2: Racemic Allylic Alkylation. 
Oven-dried half-dram vials were charged with the Pd(PPh3)4 (0.1 equiv) and substrate (1.0 equiv) and 
toluene (0.1 M) in a nitrogen-filled glovebox. The reaction vials were tightly capped and removed from 
the glovebox. After 24 hours at ambient temperature or heating at the desired temperatures, the solvent 
was removed by vacuo. The crude mixture were separated on the preparative thin layer plate, filtered, 
washed with Et2O, removed solvent to give the desired racemic products. 
Representative Procedure 3: Racemic Allylic Alkylation. 
Oven-dried half-dram vials were charged with the palladium source (Pd2dba3 or Pd2pmdba3, 0.05 equiv) 
and Gly-PHOX (0.125 equiv) and toluene (0.1 M) in nitrogen-filled glovebox. After stirring at ambient 
glovebox temperature (~28 °C) for 30 min, solutions of the substrates (1.0 equiv) in toluene were added. 
The reaction vials were tightly capped and removed from the glovebox. After 24 hours at ambient tem-
perature or heating at the desired temperatures, the solvent was removed by vacuo. The crude mixture 
were separated on the preparative thin layer plate, filtered, washed with Et2O, removed solvent to give 
desired racemic products. 
Representative Procedure 4: Preparatory Scale Reaction. 
An oven-dried 250 mL Schlenck flask was charged with Pd2dba3 (94 mg, 0.103 mmol, 0.05 equiv) and  
(S)-(CF3)3-t-Bu-PHOX (152 mg, 0.26 mmol, 0.125 equiv) and toluene (12 mL) in a nitrogen-filled 
glovebox. After stirring at ambient glovebox temperature (~28 °C) for 30 min, a solution of 4c (512 mg, 
2.06 mmol, 1.0 equiv) in 50 mL of toluene was added. The reaction vessel was sealed and removed 
from the glovebox. After 24 hours at ambient temperature the solvent was removed in vacuo. The prod-
uct was purified by column chromatography (SiO2,  5% EtOAc in hexanes) to afford 5c (419 mg, 99% 
yield, 92% ee). 
 
 
(S)-2-allyl-2-(2,2,2-trifluoroethyl)-3,4-dihydronaphthalen-1(2H)-one (5a): 26.5 mg, 99% yield; col-
orless oil; Rf = 0.47 (10:1 Hexane:EtOAc); 1H NMR (500 MHz, CDCl3) δ 8.07 (dd, J = 7.9, 1.4 Hz, 1H), 
7.50 (app td, J = 7.5, 1.5 Hz, 1H), 7.33 (app t, J = 7.6 Hz, 1H), 7.24 (d, J = 7.8 Hz, 1H), 5.72 (ddt, J = 
17.4, 10.1, 7.4 Hz, 1H), 5.19 (d, J = 10.1 Hz, 1H), 5.12 (dd, J = 16.9, 1.6 Hz, 1H), 3.14 (ddd, J = 16.9, 
11.6, 4.9 Hz, 1H), 3.00 – 2.82 (m, 2H), 2.49 (dd, J = 14.3, 7.4 Hz, 1H), 2.41 – 2.24 (m, 3H), 2.17 (dt, J 
= 14.0, 4.4 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 198.27, 142.73, 133.72, 132.15, 130.92, 128.88, 
128.58, 127.08, 126.79 (q, JC-F = 277.8 Hz, 1C), 120.17, 45.95, 38.58, 37.54 (d, JC-F = 28.8 Hz, 1C), 
29.60 (q, JC-F = 1.7 Hz, 1C), 24.88. 19F NMR (282 MHz, CDCl3) δ -58.69 (t, J = 11.7 Hz, 3F). IR (thin 
film, NaCl) 1683, 1600, 1256, 1130, 740 cm-1. HRMS (FAB) m/z calc’d for C15H16F3O [M+H]+: 
269.1148, found: 269.1159. 
 
 
(R)-2-allyl-2-(3,3,3-trifluoropropyl)-3,4-dihydronaphthalen-1(2H)-one (5b): 27.4 mg, 97% yield; 
colorless oil; Rf = 0.50 (10:1 Hexane:EtOAc); 1H NMR (500 MHz, CDCl3) δ 8.04 (ddd, J = 7.9, 1.4, 0.5 
Hz, 1H), 7.49 (app td, J = 7.5, 1.5 Hz, 1H), 7.32 (app t, J = 7.6 Hz, 1H), 7.24 (d, J = 7.5 Hz, 1H), 5.75 
(ddt, J = 16.8, 10.2, 7.4 Hz, 1H), 5.23 – 5.04 (m, 2H), 3.07 (ddd, J = 17.5, 7.9, 5.6 Hz, 1H), 2.99 (dt, J = 
17.5, 6.0 Hz, 1H), 2.45 (ddt, J = 14.2, 7.3, 1.2 Hz, 1H), 2.33 (ddt, J = 14.1, 7.4, 1.2 Hz, 1H), 2.24 – 2.01 
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(m, 4H), 1.97 (td, J = 13.7, 4.4 Hz, 1H), 1.79 (td, J = 13.5, 4.2 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 
200.39, 142.94, 133.64, 132.82, 131.53, 128.91, 128.23, 127.42 (q, JC-F = 276.9 Hz, 1C), 127.02, 119.27, 
46.63, 38.72, 31.04, 28.93 (q, JC-F = 28.8 Hz, 1C), 26.54 (q, JC-F = 3.3 Hz, 1C), 24.99. 19F NMR (282 
MHz, CDCl3) δ -66.62 (t, J = 10.4 Hz, 3F). IR (thin film, NaCl) 1682, 1601, 1259, 1136, 743 cm-1. 
HRMS (APCI/ESI) m/z calc’d for C16H18F3O [M+H]+: 283.1304, found: 283.1305.  
 
 
(R)-2-allyl-2-fluoro-3,4-dihydronaphthalen-1(2H)-one (5c)14,15: 20.3 mg, 99% yield; colorless oil; Rf 
= 0.28 (10:1 Hexane:EtOAc); 1H NMR (500 MHz, CDCl3) δ 8.06 (dd, J = 7.8, 1.4 Hz, 1H), 7.52 (app td, 
J = 7.5, 1.5 Hz, 1H), 7.35 (app td, J = 7.5, 1.1 Hz, 1H), 7.28 – 7.24 (m, 1H), 5.95 – 5.84 (m, 1H), 5.25 – 
5.07 (m, 2H), 3.19 – 3.07 (m, 1H), 3.02 (ddd, J = 17.3, 9.6, 5.3 Hz, 1H), 2.77 – 2.66 (m, 1H), 2.64 – 
2.49 (m, 1H), 2.48 – 2.26 (m, 2H). 13C NMR (101 MHz, CDCl3) δ 194.12 (d, JC-F = 17.6 Hz, 1C), 
142.82, 134.20, 130.97 (d, JC-F = 4.1 Hz, 1C), 128.87, 128.40, 128.39, 127.23, 120.01, 95.11 (d, JC-F = 
185.0 Hz, 1C), 38.09 (d, JC-F = 23.5 Hz, 1C), 32.01 (d, JC-F = 22.6 Hz, 1C), 26.01 (d, JC-F = 10.1 Hz, 1C). 
19F NMR (282 MHz, CDCl3) δ -159.85 – -160.09 (m, 1F). IR (thin film, NaCl) 1678, 1602, 1221, 930, 
741 cm-1. HRMS (APCI/ESI) m/z calc’d for C13H14FO [M+H]+: 205.1023, found: 205.1023.  
 
 
(R)-2-(2-chloroallyl)-2-fluoro-3,4-dihydronaphthalen-1(2H)-one (5d): 22.9 mg, 96% yield; colorless 
oil; Rf = 0.43 (10:1 Hexane:EtOAc); 1H NMR (500 MHz, CDCl3) δ 8.06 (dd, J = 7.8, 1.3 Hz, 1H), 7.54 
(app td, J = 7.5, 1.5 Hz, 1H), 7.36  (app t, J = 7.8 Hz, 1H), 7.28 (d, J = 7.8 Hz, 1H), 5.45 (d, J = 1.2 Hz, 
1H), 5.39 (d, J = 0.7 Hz, 1H), 3.24 – 3.01 (m, 3H), 2.90 (dd, J = 27.4, 15.3 Hz, 1H), 2.60 – 2.42 (m, 2H).  
13C NMR (101 MHz, CDCl3) δ 192.92 (d, JC-F = 18.5 Hz, 1C), 142.94, 134.78 (d, JC-F = 2.6 Hz, 1C), 
134.41, 130.74, 128.88, 128.60 (d, JC-F = 1.2 Hz, 1C), 127.31, 118.62 (d, JC-F = 1.1 Hz, 1C), 94.03 (d, JC-
F = 185.8 Hz, 1C), 42.67 (d, JC-F = 24.4 Hz, 1C), 31.69 (d, JC-F = 22.3 Hz, 1C), 26.00 (d, JC-F = 9.9 Hz, 
1C). 19F NMR (282 MHz, CDCl3) δ -158.17 – -158.43 (m, 1F).  IR (thin film, NaCl) 1680, 1631, 1602, 
1223, 743 cm-1. HRMS (APCI/ESI) m/z calc’d for C13H13ClFO [M+H]+: 239.0633, found: 239.0633. 
 
 
(S)-2-(2-fluoroallyl)-2-methyl-3,4-dihydronaphthalen-1(2H)-one (5e): 20.0 mg, 92% yield; colorless 
oil; Rf = 0.53 (10:1 Hexane:EtOAc); 1H NMR (500 MHz, CDCl3) δ 8.04 (dd, J = 7.9, 1.4 Hz, 1H), 7.47 
(app td, J = 7.4, 1.5 Hz, 1H), 7.31 (app t, J = 7.5 Hz, 1H), 7.23 (d, J = 7.7 Hz, 1H), 4.64 (dd, J = 17.2, 
2.6 Hz, 1H), 4.32 (dd, J = 49.5, 2.6 Hz, 1H), 3.09 – 2.94 (m, 2H), 2.66 (dd, J = 20.5, 14.6 Hz, 1H), 2.50 
(dd, J = 25.1, 14.6 Hz, 1H), 2.17 (dddd, J = 14.4, 9.1, 5.2, 1.3 Hz, 1H), 2.04 (dddd, J = 13.8, 6.0, 5.0, 
1.1 Hz, 1H), 1.26 (d, J = 0.9 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 201.14, 164.07 (d, JC-F = 157.8 Hz, 
1C), 143.28, 133.41, 131.34, 128.81, 128.28, 126.86, 93.85 (d, JC-F = 20.2 Hz, 1C), 44.26 (d, JC-F = 3.3 
Hz, 1C), 39.39 (d, JC-F = 25.7 Hz, 1C), 33.30 (d, JC-F = 1.8 Hz, 1C), 25.48, 21.94 (d, JC-F = 1.5 Hz, 1C).  
19F NMR (282 MHz, CDCl3) δ -88.59 – -88.99 (m, 1F). IR (thin film, NaCl) 1680, 1601, 1222, 741 cm-1. 
HRMS (APCI/ESI) m/z calc’d for C14H16FO [M+H]+: 219.1180, found: 219.1185. 
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(R)-2-allyl-2-(trifluoromethyl)-3,4-dihydronaphthalen-1(2H)-one (5f)9: 22.8 mg, 90% yield; color-
less oil; Rf = 0.36 (10:1 Hexane:EtOAc); 1H NMR (500 MHz, CDCl3) δ 8.07 (dd, J = 7.9, 1.4 Hz, 1H), 
7.51 (app td, J = 7.5, 1.5 Hz, 1H), 7.34 (app t, J = 7.6 Hz, 1H), 7.25 (d, J = 7.9 Hz, 1H), 5.87 – 5.65 (m, 
1H), 5.21 – 5.11 (m, 2H), 3.10 (dt, J = 17.5, 6.7 Hz, 1H), 3.02 (dt, J = 17.3, 6.1 Hz, 1H), 2.76 (dd, J = 
14.3, 7.3 Hz, 1H), 2.59 (dd, J = 14.3, 2.6 Hz, 1H), 2.43 – 2.25 (m, 2H). 13C NMR (101 MHz, CDCl3) δ 
192.89, 143.09, 134.20, 131.84, 131.57 (d, J = 1.5 Hz), 128.88, 128.50, 127.18, 126.57 (q, JC-F = 285.3 
Hz, 1C), 120.08, 53.58 (q, JC-F = 22.3 Hz, 1C), 35.56 (q, JC-F = 2.2 Hz, 1C), 26.47 (q, JC-F = 2.0 Hz, 1C), 
24.71. 19F NMR (282 MHz, CDCl3) δ -69.26 (s, 3F). IR (thin film, NaCl) 1688, 1601, 1161, 741cm-1. 
 
 
 
(R)-2-allyl-2-(2,2,2-trifluoroethyl)-2,3-dihydro-1H-inden-1-one (5g): 21.8 mg, 86% yield; colorless 
oil; Rf = 0.40 (10:1 Hexane:EtOAc); 1H NMR (500 MHz, CDCl3) δ 7.77 (d, J = 7.7 Hz, 1H), 7.62 (app 
td, J = 7.5, 1.2 Hz, 1H), 7.45 (d, J = 7.7 Hz, 1H), 7.40 (app t, J = 7.4 Hz, 1H), 5.58 – 5.47 (m, 1H), 5.19 
– 4.96 (m, 2H), 3.36 (d, J = 17.6 Hz, 1H), 3.14 (d, J = 17.6 Hz, 1H), 2.64 – 2.48 (m, 2H), 2.45 (dd, J = 
13.7, 6.7 Hz, 1H), 2.34 (dd, J = 13.7, 8.0 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 207.28, 152.43, 
135.55, 135.38, 131.99, 127.87, 126.60 (q, JC-F = 278.7 Hz, 1C), 126.59, 124.51, 119.93, 49.03 (d, JC-F = 
1.7 Hz, 1C), 42.44, 39.20 (q, JC-F = 27.7 Hz, 1C), 36.24 (q, JC-F = 1.9 Hz, 1C). 19F NMR (282 MHz, 
CDCl3) δ -59.71 (t, J = 11.3 Hz, 3F). IR (thin film, NaCl) 1715, 1608, 1258, 1122 cm-1. HRMS (FAB+) 
m/z calc’d for C14H14F3O [M+H]+: 255.0991, found: 255.0995. 
 
 
(R)-2-allyl-2-(3,3,3-trifluoropropyl)-2,3-dihydro-1H-inden-1-one (5h): 24.8 mg, 92% yield; colorless 
oil; Rf = 0.41 (10:1 Hexane:EtOAc); 1H NMR (500 MHz, CDCl3) δ 7.75 (app dt, J = 7.6, 0.9 Hz, 1H), 
7.62 (app td, J = 7.5, 1.2 Hz, 1H), 7.45 (app dt, J = 7.7, 0.9 Hz, 1H), 7.39 (app t, J = 7.6 Hz, 1H), 5.53 
(dddd, J = 16.8, 10.1, 8.0, 6.7 Hz, 1H), 5.12 (dq, J = 16.9, 1.5 Hz, 1H), 5.03 (dd, J = 10.1, 1.0 Hz, 1H), 
3.17 (dd, J = 17.4, 0.9 Hz, 1H), 2.91 (d, J = 17.4 Hz, 1H), 2.42 (ddt, J = 13.7, 6.6, 1.3 Hz, 1H), 2.34 (ddt, 
J = 13.7, 8.1, 1.0 Hz, 1H), 2.16 – 1.90 (m, 3H), 1.86 – 1.74 (m, 1H). 13C NMR (101 MHz, CDCl3) δ 
209.23, 152.52, 136.37, 135.51, 132.76, 127.92, 127.09 (q, JC-F = 276.0 Hz, 1C), 126.67, 124.31, 119.33, 
50.95, 41.37, 37.27, 31.54 – 27.19 (m, 2C). 19F NMR (282 MHz, CDCl3) δ -66.65 (t, J = 10.3 Hz, 3F). 
IR (thin film, NaCl) 1709, 1608, 1256, 1150 cm-1. HRMS (APCI/ESI) m/z calc’d for C15H16F3O 
[M+H]+: 269.1148, found: 269.1158. 
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(R)-2-fluoro-2-(2-fluoroallyl)-2,3-dihydro-1H-inden-1-one (5i): 20.0 mg, 96% yield; colorless oil; Rf 
= 0.30 (5:1 Hexane:EtOAc); 1H NMR (500 MHz, CDCl3) δ 7.82 (ddd, J = 7.7, 1.3, 0.7 Hz, 1H), 7.67 
(App td, J = 7.5, 1.3 Hz, 1H), 7.50 – 7.40 (m, 2H), 4.71 (dd, J = 17.0, 3.0 Hz, 1H), 4.48 (dd, J = 49.1, 
3.0 Hz, 1H), 3.61 (ddt, J = 17.8, 13.7, 0.7 Hz, 1H), 3.40 (dd, J = 23.7, 17.8 Hz, 1H), 3.00 (ddd, J = 22.5, 
15.1, 10.7 Hz, 1H), 2.77 – 2.63 (m, 1H). 13C NMR (101 MHz, CDCl3) δ 199.64 (d, JC-F = 17.6 Hz, 1C), 
160.59 (dd, JC-F = 257.4, 7.6 Hz, 1C), 150.61 (d, JC-F = 3.4 Hz, 1C), 136.67, 133.63 (d, JC-F = 1.2 Hz, 1C), 
128.49, 126.85 (d, JC-F = 1.2 Hz, 1C), 125.33, 95.17 (dd, JC-F = 18.7, 1.3 Hz, 1C), 94.75 (dd, JC-F = 188.4, 
2.4 Hz, 1C), 37.73 (dd, JC-F = 24.6, 2.3 Hz, 1C), 37.28 (t, JC-F = 27.1 Hz, 1C). 19F NMR (282 MHz, 
CDCl3) δ -92.01 – -92.40 (m, 1F), -154.37 – -154.65 (m, 1F). IR (thin film, NaCl) 1732, 1608, 1227, 
730 cm-1. HRMS (APCI/ESI) m/z calc’d for C12H11F2O [M+H]+: 209.0772, found: 209.0770. 
 
 
(S)-2-(2-fluoroallyl)-2-methyl-2,3-dihydro-1H-inden-1-one (5j): 21.8 mg, 97% yield; colorless oil; Rf 
= 0.33 (10:1 Hexane:EtOAc); 1H NMR (500 MHz, CDCl3) δ 7.76 (dt, J = 7.6, 1.0 Hz, 1H), 7.60 (app td, 
J = 7.4, 1.2 Hz, 1H), 7.44 (dt, J = 7.7, 1.0 Hz, 1H), 7.38 (app td, J = 7.4, 0.9 Hz, 1H), 4.58 (ddd, J = 
17.3, 2.8, 0.7 Hz, 1H), 4.30 (ddd, J = 49.6, 2.8, 0.7 Hz, 1H), 3.36 (d, J = 17.3 Hz, 1H), 2.93 (d, J = 17.3 
Hz, 1H), 2.58 – 2.45 (m, 2H), 1.25 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 209.74, 164.02 (d, JC-F = 
258.2 Hz, 1C), 152.63, 135.20, 127.66, 126.76, 124.62, 93.46 (d, JC-F = 19.9 Hz, 1C), 47.85 (d, JC-F = 
2.8 Hz, 1C), 43.62 – 34.74 (m, 2C), 24.19. 19F NMR (282 MHz, CDCl3) δ -91.35 – -91.74 (m, 1F).  IR 
(thin film, NaCl) 1732, 1608, 1227, 730 cm-1. HRMS (APCI/ESI) m/z calc’d for C13H14FO [M+H]+: 
205.1023, found: 205.1022.  
 
 
(R)-3-allyl-1-benzoyl-3-(3,3,3-trifluoropropyl)piperidin-2-one (5k): 27.4 mg, 94% yield; colorless 
oil; Rf = 0.37 (3:1 Hexane:EtOAc); 1H NMR (500 MHz, CDCl3) δ 7.55 – 7.47 (m, 3H), 7.40 – 7.38 (m, 
2H), 5.72 (ddt, J = 17.4, 10.2, 7.3 Hz, 1H), 5.22 – 5.15 (m, 2H), 3.84 – 3.71 (m, 2H), 2.55 (ddt, J = 13.9, 
7.2, 1.2 Hz, 1H), 2.38 (ddt, J = 13.9, 7.5, 1.2 Hz, 1H), 2.21 – 1.93 (m, 5H), 1.93 – 1.86 (m, 2H), 1.84 – 
1.77 (m, 1H). 13C NMR (101 MHz, CDCl3) δ 177.21, 175.61, 136.46, 132.11, 131.79, 128.44 (2C), 
127.47 (2C), 127.23 (q, JC-F = 276.9 Hz, 1C), 120.09, 47.20, 46.09, 41.13, 31.62, 29.32, 29.13 (q, JC-F = 
28.8 Hz, 1C), 19.41. 19F NMR (282 MHz, CDCl3) δ -66.53 (t, J = 10.5 Hz, 3F). IR (thin film, NaCl) 
2950, 1682, 1258, 1149 cm-1; HRMS (APCI/ESI) m/z calc’d for C18H21F3NO2 [M+H]+: 340.1519, found: 
340.1519. 
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(S)-1-benzoyl-3-(2-fluoroallyl)-3-methylpiperidin-2-one (5l): 23.5 mg, 85% yield; colorless oil; Rf = 
0.52 (3:1 Hexane:EtOAc); 1H NMR (500 MHz, CDCl3) δ 7.55 – 7.50 (m, 2H), 7.49 – 7.44 (m, 1H), 7.41 
– 7.35 (m, 2H), 4.67 (ddd, J = 17.3, 2.7, 0.7 Hz, 1H), 4.32 (ddd, J = 49.7, 2.7, 0.5 Hz, 1H), 4.00 – 3.84 
(m, 1H), 3.79 – 3.62 (m, 1H), 2.76 (dd, J = 19.4, 14.6 Hz, 1H), 2.41 (ddd, J = 24.8, 14.6, 0.8 Hz, 1H), 
2.19 – 1.95 (m, 3H), 1.93 – 1.75 (m, 1H), 1.42 (s, 3H).  13C NMR (101 MHz, CDCl3) δ 176.80 (d, JC-F = 
289.8 Hz, 1C), 163.47 (d, JC-F = 258.1 Hz, 1C), 136.47, 131.55, 128.28 (2C), 127.52 (2C), 94.42 (d, JC-F 
= 20.0 Hz, 1C), 47.16, 43.60 (d, JC-F = 3.1 Hz, 1C), 41.10 (d, JC-F = 25.5 Hz, 1C), 33.28 (d, JC-F = 1.9 Hz, 
1C), 25.83 (d, JC-F = 1.5 Hz, 1C), 19.72. 19F NMR (282 MHz, CDCl3) δ -89.31 – 89.70 (m, 1F).  IR (thin 
film, NaCl) 2942, 1697, 1672, 1277, 1144 cm-1. HRMS (APCI/ESI) m/z calc’d for C16H19FNO2 [M+H]+: 
276.1394, found: 276.1397. 
 
 
(R)-3-allyl-1-(benzyloxy)-3-(3,3,3-trifluoropropyl)piperidine-2,6-dione (5m): 33.0 mg, 93% yield; 
colorless oil; Rf = 0.24 (3:1 Hexane:EtOAc); 1H NMR (500 MHz, CDCl3) δ 7.51 – 7.46 (m, 2H), 7.40 – 
7.34 (m, 3H), 5.61 (ddt, J = 17.4, 10.1, 7.4 Hz, 1H), 5.25 – 5.06 (m, 2H), 5.02 (s, 2H), 2.83 – 2.70 (m, 
2H), 2.39 (ddt, J = 14.2, 7.3, 1.2 Hz, 1H), 2.30 (ddt, J = 14.2, 7.4, 1.1 Hz, 1H), 2.09 – 1.94 (m, 2H), 
1.90 – 1.80 (m, 2H), 1.78 – 1.66 (m, 2H).  13C NMR (101 MHz, CDCl3) δ 171.63, 167.45, 133.67, 
131.03, 130.38 (2C), 129.45, 128.54 (2C), 126.88 (q, JC-F = 275.9 Hz, 1C), 120.75, 78.04, 45.18, 39.76, 
29.22, 28.75 (q, JC-F = 29.2Hz, 1C), 27.76 (q, J = 3.0 Hz, 1C), 25.35. 19F NMR (282 MHz, CDCl3) δ -
66.56 (t, J = 10.1 Hz, 3F).  IR (thin film, NaCl) 1741, 1702, 1258, 1184 cm-1. HRMS (APCI/ESI) m/z 
calc’d for C18H21F3NO3 [M+H]+: 356.1468, found: 356.1470. 
 
 
(R)-3-allyl-1-benzoyl-3-(3,3,3-trifluoropropyl)pyrrolidin-2-one (5n): 26.7 mg, 82% yield; colorless 
oil; Rf = 0.35 (5:1 Hexane:EtOAc); 1H NMR (500 MHz, CDCl3) δ 7.58 – 7.51 (m, 3H), 7.45 – 7.39 (m, 
2H), 5.76 (dddd, J = 17.1, 10.2, 7.8, 7.0 Hz, 1H), 5.29 – 5.16 (m, 2H), 3.96 – 3.85 (m, 2H), 2.38 (ddt, J 
= 13.8, 7.0, 1.3 Hz, 1H), 2.34 – 2.28 (m, 1H), 2.28 – 2.06 (m, 3H), 1.95 (ddd, J = 13.3, 8.3, 6.4 Hz, 1H), 
1.86 – 1.81 (m, 2H). 13C NMR (101 MHz, CDCl3) δ 176.93, 170.74, 134.18, 132.23, 131.91, 128.90 
(2C), 128.00 (2C), 127.0 (q, JC-F = 276.9 Hz, 1C), 120.39, 48.44, 42.96, 39.93, 28.94 (q, JC-F = 29.2 Hz, 
1C), 28.02 (q, JC-F = 3.0 Hz, 1C), 27.60.  19F NMR (282 MHz, CDCl3) δ -66.60 (t, J = 10.4 Hz, 3F). IR 
(thin film, NaCl) 1738, 1678, 1305, 1258, 1138 cm-1. HRMS (APCI/ESI) m/z calc’d for C17H19F3NO2 
[M+H]+: 326.1362, found: 326.1352. 
 
Methods for the Determination of Enantiomeric Excess (ee) & Optical Rotation: 
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assay
conditionsproducts
[α]D25 
(c = 1, CHCl3)
-21.307
-28.692
-25.986
-28.049
79
-32.885
-31.191
-9.688
-85.633
74
89
89
97
+0.267
ee
(%)
90
93
90
87
95
64
85
79
92
-58.663
-5.691
-65.009
+3.302
-14.268
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O
CF3
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SFC, Chiralcel OD-H
0% IPA isocratic, 2.5 mL/min
t (major) = 9.21
t (minor) = 8.65
SFC, Chiralcel OD-H
1% IPA isocratic, 2.5 mL/min
t (major) = 5.71
t (minor) = 8.86
SFC, Chiralcel OJ-H
0% IPA isocratic, 2.5 mL/min
t (major) = 6.38
t (minor) = 5.98
SFC, Chiralpak AD-H
3% IPA isocratic, 2.5 mL/min
t (major) = 9.73
t (minor) = 11.11
SFC, Chiralpak IC
5% IPA isocratic, 2.5 mL/min
t (major) = 4.78
t (minor) = 4.21
SFC, Chiralpak AS-H
0% IPA isocratic, 2.5 mL/min
t (major) = 2.81
t (minor) = 2.55
SFC, Chiralpak AD-H
5% IPA isocratic, 2.5 mL/min
t (major) = 2.72
t (minor) = 3.04
SFC, Chiralpak AD-H
3% IPA isocratic, 2.5 mL/min
t (major) = 3.85
t (minor) = 3.16
5a
5b
5c
5d
5e
5f
5g
5h
5i
5j
5k
5l
5m
5n
SFC, Chiralpak AD-H
5% IPA isocratic, 2.5 mL/min
t (major) = 2.98
t (minor) = 3.54
O
F
SFC, Chiralpak IC
3% IPA isocratic, 2.5 mL/min
t (major) = 8.09
t (minor) = 7.23
N
O
Bz
CF3
SFC, Chiralpak AD-H
5% IPA isocratic, 2.5 mL/min
t (major) = 6.15
t (minor) = 4.63
N
O
Bz
F
SFC, Chiralpak AD-H
5% IPA isocratic, 2.5 mL/min
t (major) = 9.04
t (minor) = 11.38
SFC, Chiralcel OJ-H
3% IPA isocratic, 2.5 mL/min
t (major) = 10.67
t (minor) = 9.86
SFC, Chiralpak AD-H
10% IPA isocratic, 2.5 mL/min
t (major) = 2.28
t (minor) = 3.25
N
O
BnO
O
CF3
N
O
CF3Bz
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